Search research articles
Contact Us
Filters
Showing results (41-50 of 86) with videos related to
Page
of 9
Sort By:
World Journal of Psychiatry
|
October 3, 2022
Galectin-3 mediated risk of inflammation in stable schizophrenia, with only possible secondary consequences for cognition
Slavica Minic Janicijevic, Ivan P Jovanovic, Nevena M Gajovic, et al.
Cytokine
|
August 24, 2018
Role of IL-6/RORC/IL-22 axis in driving Th17 pathway mediated immunopathogenesis of schizophrenia
Manjula Subbanna, Venkataram Shivakumar, Pinku Mani Talukdar, et al.
Journal of Psychiatric Research
|
April 4, 2021
Reduced T cell immunity in unmedicated, comorbidity-free obsessive-compulsive disorder: An immunophenotyping study
Manjula Subbanna, Venkataram Shivakumar, Dania Jose, et al.
Asian Journal of Psychiatry
|
December 15, 2016
The impact of IL10 polymorphisms and sHLA-G levels on the risk of schizophrenia
Ashwini Rajasekaran, Venkataram Shivakumar, Sunil V Kalmady, et al.
Cytokine
|
December 9, 2017
Influence of correlation between HLA-G polymorphism and Interleukin-6 (IL6) gene expression on the risk of schizophrenia
Venkataram Shivakumar, Monojit Debnath, Deepthi Venugopal, et al.
Journal of the Peripheral Nervous System : JPNS
|
February 9, 2022
Variations within Toll-like receptor (TLR) and TLR signaling pathway-related genes and their synergistic effects on the risk of Guillain-Barré syndrome
Debprasad Dutta, Madhu Nagappa, Binu V Sreekumaran Nair, et al.
Cells
|
May 14, 2022
Adverse Childhood Experiences Predict the Phenome of Affective Disorders and These Effects Are Mediated by Staging, Neuroimmunotoxic and Growth Factor Profiles
Michael Maes, Muanpetch Rachayon, Ketsupar Jirakran, et al.
Medicine
|
October 26, 2019
Yoga and schizophrenia-a comprehensive assessment of neuroplasticity: Protocol for a single blind randomized controlled study of yoga in schizophrenia
Shivarama Varambally, Ganesan Venkatasubramanian, Ramajayam Govindaraj, et al.
International Journal of Yoga
|
March 11, 2024
Long-term Add-on Yoga Therapy Modulates Oxidative Stress Pathway and Offers Clinical Benefits in Major Depressive Disorder: A Randomized Controlled Trial
Pinku Mani Talukdar, Preethi V Reddy, Praerna Hemant Bhargav, et al.
Human Immunology
|
August 29, 2016
The impact of HLA-G 3' UTR variants and sHLA-G on risk and clinical correlates of schizophrenia
Ashwini Rajasekaran, Venkataram Shivakumar, Sunil V Kalmady, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 86) with videos related to
Sort By:
Page
of 9
World Journal of Psychiatry
|
October 3, 2022
Galectin-3 mediated risk of inflammation in stable schizophrenia, with only possible secondary consequences for cognition
Slavica Minic Janicijevic, Ivan P Jovanovic, Nevena M Gajovic, et al.
Cytokine
|
August 24, 2018
Role of IL-6/RORC/IL-22 axis in driving Th17 pathway mediated immunopathogenesis of schizophrenia
Manjula Subbanna, Venkataram Shivakumar, Pinku Mani Talukdar, et al.
Journal of Psychiatric Research
|
April 4, 2021
Reduced T cell immunity in unmedicated, comorbidity-free obsessive-compulsive disorder: An immunophenotyping study
Manjula Subbanna, Venkataram Shivakumar, Dania Jose, et al.
Asian Journal of Psychiatry
|
December 15, 2016
The impact of IL10 polymorphisms and sHLA-G levels on the risk of schizophrenia
Ashwini Rajasekaran, Venkataram Shivakumar, Sunil V Kalmady, et al.
Cytokine
|
December 9, 2017
Influence of correlation between HLA-G polymorphism and Interleukin-6 (IL6) gene expression on the risk of schizophrenia
Venkataram Shivakumar, Monojit Debnath, Deepthi Venugopal, et al.
Journal of the Peripheral Nervous System : JPNS
|
February 9, 2022
Variations within Toll-like receptor (TLR) and TLR signaling pathway-related genes and their synergistic effects on the risk of Guillain-Barré syndrome
Debprasad Dutta, Madhu Nagappa, Binu V Sreekumaran Nair, et al.
Cells
|
May 14, 2022
Adverse Childhood Experiences Predict the Phenome of Affective Disorders and These Effects Are Mediated by Staging, Neuroimmunotoxic and Growth Factor Profiles
Michael Maes, Muanpetch Rachayon, Ketsupar Jirakran, et al.
Medicine
|
October 26, 2019
Yoga and schizophrenia-a comprehensive assessment of neuroplasticity: Protocol for a single blind randomized controlled study of yoga in schizophrenia
Shivarama Varambally, Ganesan Venkatasubramanian, Ramajayam Govindaraj, et al.
International Journal of Yoga
|
March 11, 2024
Long-term Add-on Yoga Therapy Modulates Oxidative Stress Pathway and Offers Clinical Benefits in Major Depressive Disorder: A Randomized Controlled Trial
Pinku Mani Talukdar, Preethi V Reddy, Praerna Hemant Bhargav, et al.
Human Immunology
|
August 29, 2016
The impact of HLA-G 3' UTR variants and sHLA-G on risk and clinical correlates of schizophrenia
Ashwini Rajasekaran, Venkataram Shivakumar, Sunil V Kalmady, et al.
Page
of 9